Connor, Clark & Lunn Investment Management (CC&L)’s Myovant Sciences Ltd. MYOV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-84,086
| Closed | -$1.05M | – | 1283 |
|
|
2022
Q2 | $1.05M | Sell |
84,086
-56,237
| -40% | -$699K | 0.01% | 615 |
|
|
2022
Q1 | $1.87M | Sell |
140,323
-46,844
| -25% | -$624K | 0.01% | 516 |
|
|
2021
Q4 | $2.91M | Sell |
187,167
-24,949
| -12% | -$388K | 0.01% | 447 |
|
|
2021
Q3 | $4.76M | Sell |
212,116
-27,244
| -11% | -$611K | 0.02% | 349 |
|
|
2021
Q2 | $5.45M | Buy |
239,360
+13,410
| +6% | +$305K | 0.03% | 338 |
|
|
2021
Q1 | $4.65M | Buy |
225,950
+5,035
| +2% | +$104K | 0.03% | 373 |
|
|
2020
Q4 | $6.1M | Sell |
220,915
-16,411
| -7% | -$453K | 0.04% | 297 |
|
|
2020
Q3 | $3.33M | Sell |
237,326
-116,381
| -33% | -$1.63M | 0.02% | 377 |
|
|
2020
Q2 | $7.29M | Buy |
353,707
+24,457
| +7% | +$504K | 0.05% | 239 |
|
|
2020
Q1 | $2.49M | Buy |
329,250
+139,039
| +73% | +$1.05M | 0.02% | 379 |
|
|
2019
Q4 | $2.95M | Buy |
+190,211
| New | +$2.95M | 0.02% | 351 |
|